The 4H Syndrome Gene Panel is a genetic test used to identify mutations associated with 4H syndrome, a rare inherited neurological disorder. The name 4H stands for Hypomyelination, Hypodontia, and Hypogonadotropic Hypogonadism. This condition primarily affects the brain's white matter, dental development, and hormonal function.
Genes Analyzed
The panel typically includes:
POLR3A
POLR3B
POLR1C
POLR3K (where clinically indicated)
These genes are responsible for the majority of genetically confirmed cases of 4H syndrome.
Who Should Consider This Test?
This test is recommended for individuals with:
Developmental delay or regression
Progressive movement disorders (ataxia, tremors, dystonia)
MRI findings suggestive of hypomyelination
Delayed or missing permanent teeth (hypodontia)
Delayed puberty or hormone deficiencies
Family history of leukodystrophy or inherited neurological disorders
Sample Required
Peripheral Blood (EDTA)
Test Method
Next-Generation Sequencing (NGS)
Sanger Sequencing confirmation (if required)
Benefits
Confirms the genetic cause of 4H syndrome
Supports early diagnosis and clinical management
Helps guide treatment planning and supportive care
Enables genetic counseling for affected families
Assists in assessing recurrence risk for future pregnancies
Why Choose This Test?
Early genetic diagnosis helps avoid unnecessary investigations, provides clarity regarding prognosis, and enables appropriate multidisciplinary care involving neurologists, endocrinologists, dentists, and rehabilitation specialists.
Note: A positive result should always be interpreted alongside clinical findings, MRI results, and family history by a qualified healthcare professional or genetic counselor.